McKesson Corporation (LON:0JZU)
London
· Delayed Price · Currency is GBP · Price in USD 810.45
-0.14 (-0.02%)
At close: Dec 5, 2025
Revenue
Fiscal year is April - March.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2018 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2018 - 2021 |
| Prescription Technology Solutions Revenue | 5.52B | 5.22B |
Log In |
Log In |
Log In | Upgrade
|
| Medical Surgical Solutions Revenue | 11.45B | 11.39B |
Log In |
Log In |
Log In | Upgrade
|
| US Pharmaceutical Revenue | - | 327.72B |
Log In |
Log In |
Log In | Upgrade
|
| International Revenue | - | 14.72B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 370.12B | 11.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 387.09B | 359.05B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is April - March.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2018 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2018 - 2021 |
| Prescription Technology Solutions Operating Profit | 964.00M | 875.00M |
Log In |
Log In |
Log In | Upgrade
|
| Medical Surgical Solutions Operating Profit | 937.00M | 773.00M |
Log In |
Log In |
Log In | Upgrade
|
| US Pharmaceutical Operating Profit | - | 4.00B |
Log In |
Log In |
Log In | Upgrade
|
| International Operating Profit | - | -213.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | 3.36B | -1.02B |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 5.26B | 4.42B |
Log In |
Log In |
Log In | Upgrade
|
Capital Expenditures
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2017 - 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2017 - 2020 |
| US Pharmaceutical Capital Expenditures | 241.00M |
Log In |
Log In |
Log In | Upgrade
|
| Prescription Technology Solutions Capital Expenditures | 11.00M |
Log In |
Log In |
Log In | Upgrade
|
| Medical Surgical Solutions Capital Expenditures | 163.00M |
Log In |
Log In |
Log In | Upgrade
|
| International Capital Expenditures | 107.00M |
Log In |
Log In |
Log In | Upgrade
|